Gene · 8915
Papers2,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune cell landscapes are associated with high-grade serous ovarian cancer survival. | Sci Rep | 2024 | 38997411 | PubTator, text mining | PubMed |
| The Genetic Landscape of Primary Breast Marginal Zone Lymphoma Identifies a Mutational-driven Disease With Similarities to Ocular Adnexal Lymphoma. | Am J Surg Pathol | 2024 | 38864239 | PubTator, text mining | PubMed |
| MALT1 substrate cleavage: what is it good for? | Front Immunol | 2024 | 38863711 | PubTator, text mining | PubMed |
| An integrated analysis of the structural changes and gene expression of spleen in human visceral leishmaniasis with and without HIV coinfection. | PLoS Negl Trop Dis | 2024 | 38843306 | PubTator, text mining | PubMed |
| Polo-like kinase 1 (PLK1) is a novel CARD14-binding protein in keratinocytes. | Biochem Pharmacol | 2024 | 38797267 | PubTator, text mining | PubMed |
| The Concise Language Paradigm (CLaP), a framework for studying the intersection of comprehension and production: electrophysiological properties. | Brain Struct Funct | 2024 | 38748232 | PubTator, text mining | PubMed |
| Study of individual domains contributing to MALT1 dimerization in BCL10-independent and dependent assembly. | Biochem Biophys Res Commun | 2024 | 38714015 | PubTator, text mining | PubMed |
| Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy. | Signal Transduct Target Ther | 2024 | 38688914 | PubTator, text mining | PubMed |
| A case of acinar cell carcinoma originating from the accessory papilla of the duodenum. | Surg Case Rep | 2024 | 38625458 | PubTator, text mining | PubMed |
| CARMA3 Drives NF-κB Activation and Promotes Intervertebral Disc Degeneration: Involvement of CARMA3-BCL10-MALT1 Signalosome. | Inflammation | 2024 | 38607566 | PubTator, text mining | PubMed |
| Potential role of p53 deregulation in modulating immune responses in human malignancies: A paradigm to develop immunotherapy. | Cancer Lett | 2024 | 38408603 | PubTator, text mining | PubMed |
| Naturally occurring T cell mutations enhance engineered T cell therapies. | Nature | 2024 | 38326614 | PubTator, text mining | PubMed |
| Identification of gut microbes-related molecular subtypes and their biomarkers in colorectal cancer. | Aging (Albany NY) | 2024 | 38289597 | PubTator, text mining | PubMed |
Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System. | Int J Mol Sci | 2024 | 38279253 | PubTator, text mining | PubMed |
| FPFT-2216, a Novel Anti-lymphoma Compound, Induces Simultaneous Degradation of IKZF1/3 and CK1α to Activate p53 and Inhibit NFκB Signaling. | Cancer Res Commun | 2024 | 38265263 | PubTator, text mining | PubMed |
| Causal relationship between multiple sclerosis and cortical structure: a Mendelian randomization study. | J Transl Med | 2024 | 38245759 | PubTator, text mining | PubMed |
| MicroRNA‑155‑5p affects regulatory T cell activation and immunosuppressive function by targeting BCL10 in myasthenia gravis. | Exp Ther Med | 2024 | 38223327 | PubTator, text mining | PubMed |
| Exploration of Key Genes Combining with Immune Infiltration Level andTumor Mutational Burden in Hepatocellular Carcinoma. | Comb Chem High Throughput Screen | 2024 | 38213141 | PubTator, text mining | PubMed |
| Myeloid spatial and transcriptional molecular signature of ischemia-reperfusion injury in human liver transplantation. | Hepatol Commun | 2024 | 38206205 | PubTator, text mining | PubMed |
| The multifaceted interactions between Newcastle disease virus proteins and host proteins: a systematic review. | Virulence | 2024 | 38193514 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8915/papers?page=5